Package 31722-430-60

{"route": ["ORAL"], "spl_id": "35c91221-dff8-9144-e063-6394a90a57fb", "openfda": {"upc": ["0331722431309", "0331722430906", "0331722428309", "0331722430609", "0331722429306", "0331722431903"], "unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482515", "1482521", "1482525"], "spl_set_id": ["6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (31722-430-32)  / 10 TABLET in 1 BLISTER PACK (31722-430-31)", "package_ndc": "31722-430-32", "marketing_start_date": "20230803"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (31722-430-60)", "package_ndc": "31722-430-60", "marketing_start_date": "20230803"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (31722-430-90)", "package_ndc": "31722-430-90", "marketing_start_date": "20230803"}], "brand_name": "Eslicarbazepine acetate", "product_id": "31722-430_35c91221-dff8-9144-e063-6394a90a57fb", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-430", "generic_name": "Eslicarbazepine acetate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eslicarbazepine acetate", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "600 mg/1"}], "application_number": "ANDA211186", "marketing_category": "ANDA", "marketing_start_date": "20230803", "listing_expiration_date": "20261231"}